Gut microbiome health and dysbiosis: A clinical primer
- PMID: 36168753
- PMCID: PMC9827978
- DOI: 10.1002/phar.2731
Gut microbiome health and dysbiosis: A clinical primer
Abstract
The gut microbiome has been referred to as the "forgotten organ." Although much about the gut microbiome remains incompletely understood, data on its clinical importance is emerging at rapid speed. Many practicing clinicians may be unaware of the essential role that the microbiome plays in both health and disease. This review aims to improve clinical understanding of the gut microbiome by discussing key terminology and foundational concepts. The role of a healthy microbiome in normal host function is described, as well as the consequences of a disrupted microbiome (i.e., dysbiosis). Management strategies to restore the gut microbiome from a disrupted to a healthy state are also briefly discussed. Lastly, we review emerging areas for therapeutic potential and opportunity to bring determinants of microbiome health from the bench to bedside.
Keywords: Clostridioides difficile infection; dysbiosis; gut microbiome.
© 2022 The Authors. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy published by Wiley Periodicals LLC on behalf of Pharmacotherapy Publications, Inc.
Conflict of interest statement
MRB is an employee of Ferring Pharmaceuticals. TPL is a consultant for Ferring Pharmaceuticals. ALVH reports no conflicts. Authors did not receive specific funding or compensation for this work.
Figures
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
